The Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on the model/outer diameter size of the forceps. Coagulation is achieved using electrosurgical energy under visualization. The device is to be used with bipolar outputs of compatible generators. The forceps' jaws are electrically isolated from each other enabling one jaw to act as a return electrode, eliminating the need for a return pad. To transect tissue, a cutting blade is actuated and moves between the electrode jaws. The connections (bipolar electrical signal) to the forceps are through either a hardwired cable (model 3006) or a connector at the bottom of the handle (models 3000 and 3005). The device includes mechanisms (switches and triggers) to provide coagulation using the bipolar electrical energy that reaches the forceps. The forceps are positioned in the desired location for grasping, coagulation, and transection of tissue. The anatomical structure to be coagulated is placed between the open forceps jaws, and once the Forceps Grip trigger is squeezed, the forceps' jaws are closed onto tissue, followed by coagulation. The device includes a blade that is mechanically advanced to perform tissue cutting as needed.
Publicado el 14 de agosto de 2024 · Inicio del retiro: 1 de julio de 2024
Resumen
FDA registra el retiro Z-2541-2024 de dispositivos médicos de Clase II, publicado el 14 de agosto de 2024 e iniciado el 1 de julio de 2024. Empresa responsable: Olympus Corporation of the Americas; Estado: En curso; Cantidad reportada: 6985 units; Lote: UDI: 00821925035881 Batch Number: FR137723 FR139935 FR141534 FR145203 FR157420 FR165250 FR176934 FR179541 FR197926 FR204443 FR206007 FR207123 FR214689 FR215012 FR215026 FR246906 FR261731 FR297010 FR305512 FR308131 FR335638 FR335650 FR378737 FR390629 FR397748 PW308683. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Fractures and breakages in packaging trays and Tyvek covers, which may result in a sterility breach
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Olympus Corporation of the Americas
- Distribuidor
- Worldwide distribution - US Nationwide and the countries of CA, DE, AU, SG, KR.
- Lote
- UDI: 00821925035881 Batch Number: FR137723 FR139935 FR141534 FR145203 FR157420 FR165250 FR176934 FR179541 FR197926 FR204443 FR206007 FR207123 FR214689 FR215012 FR215026 FR246906 FR261731 FR297010 FR305512 FR308131 FR335638 FR335650 FR378737 FR390629 FR397748 PW308683
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAOlympus M3 Gold Autoclavable Lateral Telescope 70. Model Number: M3-70A.7 de octubre de 2026
- FDAOlympus M3 Gold Autoclavable Foroblique Telescope 30. Model Number: M3-30A.7 de octubre de 2026
- FDAOlympus Tripp-Lite P580-025 25ft DisplayPort Cable, Model Number P580-025, an accessory used in conjunction7 de octubre de 2026
- FDAOlympus BiCOAG Hemostasis Probe 10Fr Coaxial Connector. Model/Catalog Number: CD-B610LA.30 de septiembre de 2026
- FDAThe Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on14 de agosto de 2024
- FDAThe Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on14 de agosto de 2024
Preguntas sobre este retiro
¿The Everest Bipolar Cutting Forceps are intended to be passed through a 5-mm or 10-mm cannula, depending on the model/outer diameter size of the forceps. Coagulation is achieved using electrosurgical energy under visualization. The device is to be used with bipolar outputs of compatible generators. The forceps' jaws are electrically isolated from each other enabling one jaw to act as a return electrode, eliminating the need for a return pad. To transect tissue, a cutting blade is actuated and moves between the electrode jaws. The connections (bipolar electrical signal) to the forceps are through either a hardwired cable (model 3006) or a connector at the bottom of the handle (models 3000 and 3005). The device includes mechanisms (switches and triggers) to provide coagulation using the bipolar electrical energy that reaches the forceps. The forceps are positioned in the desired location for grasping, coagulation, and transection of tissue. The anatomical structure to be coagulated is placed between the open forceps jaws, and once the Forceps Grip trigger is squeezed, the forceps' jaws are closed onto tissue, followed by coagulation. The device includes a blade that is mechanically advanced to perform tissue cutting as needed. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2541-2024 el 14 de agosto de 2024. Peligro reportado: Fractures and breakages in packaging trays and Tyvek covers, which may result in a sterility breach
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter